Martha Hayden-Ledbetter

1.9k citations
18 papers · 1.5k indexed · 1 hit paper · h-index 13

Martha Hayden-Ledbetter

18 papers receiving 1.5k citations

Hit Papers

The HE4 (WFDC2) protein is a biomarker for ovarian carcin...5822003202620102018100200300400500

Peers

Martha Hayden-Ledbetter
Comparison fields: 5 of 86
  • Reproductive Medicine 405
  • Immunology 763
  • Obstetrics and Gynecology 119
  • Oncology 299
  • Immunology and Allergy 54
Replace S A Cannistra with:
S A Cannistra United States
Juan J. Roman United States
Susan C. Weil United States
Elisabetta Bandiera Italy
Katie Meehan Australia
Deyin Xing United States
Seija Grénman Finland
Kristen A. Atkins United States
Mitsuo Yoshinouchi Japan
Martha Hayden-Ledbetter relative to S A Cannistra United States S A Cannistra's profile →
Citations per field
00.5×4.8×
S A Cannistra · 1×
Citations per year

Countries citing papers authored by Martha Hayden-Ledbetter

Since Specialization
Citations

This map shows the geographic impact of Martha Hayden-Ledbetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Hayden-Ledbetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Hayden-Ledbetter more than expected).

Fields of papers citing papers by Martha Hayden-Ledbetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Hayden-Ledbetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Hayden-Ledbetter. The network helps show where Martha Hayden-Ledbetter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Martha Hayden-Ledbetter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martha Hayden-Ledbetter Line = papers co-authored together Martha Hayden-Ledbetter links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 201422
2 201333
3 200927
4 200799
5 20071
6 200661
7 20061
8 20065
9 20055
10
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.breakdown →
2003582
11 2002103
12 200211
13 2002123
14 200195
15 200165
16 200133
17 200143
18 2000205

About Martha Hayden-Ledbetter

Martha Hayden-Ledbetter is a scholar working on Immunology, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging, Oncology and Genetics, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (6 papers), T-cell and B-cell Immunology (6 papers), Virus-based gene therapy research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Reproductive Medicine (405 citations), Immunology (763 citations), Obstetrics and Gynecology (119 citations), Oncology (299 citations) and Immunology and Allergy (54 citations). Martha Hayden-Ledbetter has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Jeffrey A. Ledbetter, Ingegerd Hellström, Karl Erik Hellström, Nicole Urban, Martin McIntosh, Charles W. Drescher, Michèl Schummer, Nathalie Scholler, Amber Dahlin and Edward A. Clark. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, Blood, Nature Medicine and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026